TRXADE HEALTH, INC.

Analyst Reco. TRxADE HEALTH, Inc.

Equities

MEDS

US89846A4058

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-24 pm EDT			5-day change	1st Jan Change
6.45 ^USD	-0.77%		-8.90%	+24.13%

Apr. 22	TRxADE HEALTH, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 06	Top Midday Gainers	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EF Hutton Assumes Trxade Health at Buy With $1.25 Price Target	23-06-01	MT
Maxim Adjusts Price Target on Trxade Health to $1.75 From $2.50, Maintains Buy Rating	23-03-28	MT
Inflation, Rate-Hike Concerns Push US Equity Futures Lower	23-02-17	MT
Maxim Adjusts Price Target for TRxADE Health to $4 From $7, Maintains Buy Rating	22-05-10	MT
Maxim Adjusts TRxADE HEALTH's Price Target to $7 from $11, Maintains Buy Rating	22-03-29	MT
TRXADE : National Securities Initiates Trxade Group at Buy with $15 Price Target	20-12-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer